Expert Video - What are some of the approaches used in AML maintenance therapy?
Dr. Jamile Shammo, an expert on acute myeloid leukemia (AML) at Rush University Medical Group in Chicago, explains that the treatment of frail elderly patients with maintenance and continuous treatments requires special interventions and approaches. Even after achieving complete remission, patients with AML may relapse and maintenance treatments have been shown to benefit disease outcomes. Patients who have attained complete remission with azacitidine, at a reduced dose or treatment intensity, have been shown in clinical trials to have good outcomes.
Share with family and friends:
Click here to take our SURVEY Your feedback is important to us! We will use your feedback to develop future areas of content about AML which will help other patients, caregivers and families.
This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.
This activity is supported by educational grants from AbbVie, Acceleron, Bristol-Myers Squibb, Celgene Corporation, Daiichi Sankyo, Jazz Pharmaceuticals and Takeda Oncology.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.